Overview A Study of ABT-414 in Subjects With Solid Tumors Status: Completed Trial end date: 2015-11-01 Target enrollment: Participant gender: Summary A study of ABT-414 in subjects with solid tumors. Phase: Phase 1 Details Lead Sponsor: AbbVie (prior sponsor, Abbott)